NDC 0781-5514 – Griseofulvin
Griseofulvin 250 mg/1 · Tablet · Oral
Product NDC0781-5514
Product details
- Brand name
- Griseofulvin
- Generic name
- Griseofulvin
- Labeler
- Sandoz Inc
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA091592
- Marketed since
- August 7, 2013
- Listing expires
- December 31, 2026
- Pharmacologic class
- Tubulin Inhibiting Agent
Active ingredients
- Griseofulvin 250 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0781-5514-01 | 100 TABLET in 1 BOTTLE (0781-5514-01) | Aug 7, 2013 |
| 0781-5514-05 | 500 TABLET in 1 BOTTLE (0781-5514-05) | Aug 7, 2013 |
Other Griseofulvin products
- 0781-5515 Griseofulvin 500 mg/1 · Tablet · Sandoz Inc
- 42794-012 Griseofulvin 500 mg/1 · Tablet · Sigmapharm Laboratories, LLC
- 0472-0013 Griseofulvin 125 mg/5mL · Suspension · Actavis Pharma, Inc.
- 62135-968 Griseofulvin 125 mg/5mL · Suspension · Chartwell RX, LLC.
- 0713-0850 Griseofulvin 125 mg/5mL · Suspension · Cosette Pharmaceuticals, Inc.